Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Bernstein

Showing results (321-330 of 606) with videos related to

Pageof 61
Sort By:
Current Medical Research and Opinion|October 25, 2017
Real-world treatment patterns and outcomes of omalizumab use in patients with chronic idiopathic urticariaLiya Wang, Xuehua Ke, Abhishek Kavati, et al.
Allergy|May 26, 2025
Anti-KIT Barzolvolimab for Chronic Spontaneous UrticariaMarcus Maurer, Martin Metz, John Anderson, et al.
The World Allergy Organization Journal|November 16, 2013
Consensus Description of Inclusion and Exclusion Criteria for Clinical Studies of Nonallergic Rhinopathy (NAR), Previously Referred to as Vasomotor Rhinitis (VMR), Nonallergic Rhinitis, and/or Idiopathic RhinitisMichael A Kaliner, James N Baraniuk, Michael S Benninger, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 31, 2024
The Impact of Prior Authorization on Clinical Practice and Patient Care Outcomes: A Work Group Report of the AAAAI Prior Authorization Task ForceJonathan A Bernstein, Deepthi Gadde, Mohamed Yassin, et al.
Genome Biology|June 16, 2026
Ensilication preserves high-molecular weight native DNA for clinical long-read sequencingAlexis Ferrasse, Rodrigo Mendez, John E Gorzynski, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 12, 2023
Patient outcomes associated with subcutaneous C1INH prophylaxis for hereditary angioedema: a retrospective analysisWilliam Lumry, Timothy Craig, John Anderson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 24, 2020
Long-term safety and efficacy of subcutaneous C1-inhibitor in older patients with hereditary angioedemaJonathan A Bernstein, Lawrence Schwartz, William Yang, et al.
Pediatrics|December 13, 2016
Management of Children With Hereditary Angioedema Due to C1 Inhibitor DeficiencyMichael M Frank, Bruce Zuraw, Aleena Banerji, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 5, 2024
The Undiagnosed Diseases Network: Characteristics of solvable applicants and diagnostic suggestions for nonaccepted onesJohn J Mulvihill, Laura Findley, Weihong Ni, et al.
Therapeutic Advances in Respiratory Disease|September 5, 2024
Content validity of the Leicester Cough Questionnaire in adults with refractory or unexplained chronic cough: a qualitative interview studyAllison Martin Nguyen, Carmen La Rosa, Alexandra G Cornell, et al.
Pageof 61

Showing results (321-330 of 606) with videos related to

Sort By:
Pageof 61
Current Medical Research and Opinion|October 25, 2017
Real-world treatment patterns and outcomes of omalizumab use in patients with chronic idiopathic urticariaLiya Wang, Xuehua Ke, Abhishek Kavati, et al.
Allergy|May 26, 2025
Anti-KIT Barzolvolimab for Chronic Spontaneous UrticariaMarcus Maurer, Martin Metz, John Anderson, et al.
The World Allergy Organization Journal|November 16, 2013
Consensus Description of Inclusion and Exclusion Criteria for Clinical Studies of Nonallergic Rhinopathy (NAR), Previously Referred to as Vasomotor Rhinitis (VMR), Nonallergic Rhinitis, and/or Idiopathic RhinitisMichael A Kaliner, James N Baraniuk, Michael S Benninger, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 31, 2024
The Impact of Prior Authorization on Clinical Practice and Patient Care Outcomes: A Work Group Report of the AAAAI Prior Authorization Task ForceJonathan A Bernstein, Deepthi Gadde, Mohamed Yassin, et al.
Genome Biology|June 16, 2026
Ensilication preserves high-molecular weight native DNA for clinical long-read sequencingAlexis Ferrasse, Rodrigo Mendez, John E Gorzynski, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 12, 2023
Patient outcomes associated with subcutaneous C1INH prophylaxis for hereditary angioedema: a retrospective analysisWilliam Lumry, Timothy Craig, John Anderson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 24, 2020
Long-term safety and efficacy of subcutaneous C1-inhibitor in older patients with hereditary angioedemaJonathan A Bernstein, Lawrence Schwartz, William Yang, et al.
Pediatrics|December 13, 2016
Management of Children With Hereditary Angioedema Due to C1 Inhibitor DeficiencyMichael M Frank, Bruce Zuraw, Aleena Banerji, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 5, 2024
The Undiagnosed Diseases Network: Characteristics of solvable applicants and diagnostic suggestions for nonaccepted onesJohn J Mulvihill, Laura Findley, Weihong Ni, et al.
Therapeutic Advances in Respiratory Disease|September 5, 2024
Content validity of the Leicester Cough Questionnaire in adults with refractory or unexplained chronic cough: a qualitative interview studyAllison Martin Nguyen, Carmen La Rosa, Alexandra G Cornell, et al.
Pageof 61